Amy Straub
About Amy Straub
Amy Straub is the Executive Director, Head of Oncology Late Development Project Management at Bristol Myers Squibb in Princeton, NJ, with over 20 years of experience in the pharmaceutical industry.
Company
Amy Straub is currently associated with Bristol Myers Squibb, a leading global biopharmaceutical company. She serves in multiple leadership roles at the company's Princeton, NJ location, focusing on oncology late development project management and cell therapy project management.
Title
Amy holds the position of Executive Director, Head Of Oncology Late Development Project Management at Bristol Myers Squibb. Additionally, she serves as Tour of Duty, Head of Cell Therapy Project Management.
Education and Expertise
Amy Straub received her Ph.D. in Analytical Chemistry from the University of New Hampshire in 1991, an MBA in Business from the University of New Haven in 2002, and a BS in Chemistry from Le Moyne College in 1987. Her expertise lies in project management within the pharmaceutical industry, particularly in oncology and cell therapy.
Background
Amy Straub's professional journey includes various roles at Bristol Myers Squibb since 2003, ranging from Senior Project Manager to her current position as Executive Director. She has over 20 years of experience managing projects in the pharmaceutical industry, including her early career at Bayer as a Project Manager.
Achievements
Amy has played a significant role in advancing cancer therapies through strategic planning and execution of oncology late development projects. She was instrumental in integrating project management practices during the merger of Bristol Myers Squibb and Celgene. She is also recognized for her mentorship and development of future project management leaders within the pharmaceutical sector.